Irbesartan And Hydrochlorothiazide
Product Images NDC 71335-1392

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 71335-1392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Irbehctz 01)

A line graph showing the percentage of subjects with systolic blood pressure less than 140 mmHg plotted against baseline systolic blood pressure (mmHg). The graph includes multiple study groups labeled as irbe/HCTZ Study V, Irb. Study V, HCTZ Study V, irbe/HCTZ Study VI, and Irb. Study VI, each represented by different line styles.*

FDA Label Image

Figure 1b (Irbehctz 02)

A line graph displaying the percentage of systolic blood pressure (SBP) below 130 mmHg versus baseline SBP (mmHg) across different studies labeled irbe/HCTZ Study V, Irb. Study V, HCTZ Study V, irbe/HCTZ Study VI, and Irb. Study VI. The graph uses various line styles to differentiate between study groups.*

FDA Label Image

Figure 2a (Irbehctz 03)

A line graph depicting the percentage of patients achieving diastolic blood pressure (DBP) less than or equal to 90 mmHg plotted against baseline DBP values. The graph includes multiple study groups labeled as irbe/HCTZ Study V, Irb. Study V, HCTZ Study V, irbe/HCTZ Study VI, and Irb. Study VI, each represented by different line styles. The x-axis ranges from 90 to 130 mmHg baseline DBP and the y-axis shows the percentage from 0 to 100.*

FDA Label Image

Figure 2b (Irbehctz 04)

A line graph showing the percentage of subjects with diastolic blood pressure (DBP) below 80 mmHg plotted against baseline DBP values ranging from 90 to 130 mmHg. Different line styles represent various study groups labeled as irbe/HCTZ Study V, Irb. Study V, HCTZ Study V, irbe/HCTZ Study VI, and Irb. Study VI in the legend.*

FDA Label Image

Chemical Structure (Irbehctz 05)

Chemical structure diagram showing a molecular formula with multiple rings and functional groups. The image likely represents the chemical structure of one of the active ingredients in Irbesartan and Hydrochlorothiazide.*

FDA Label Image

Chemical Structure (Irbehctz 06)

Chemical structure diagram of the active ingredient Irbesartan and Hydrochlorothiazide, showing molecular bonds and functional groups including sulfonamide and chlorinated benzene rings.*

FDA Label Image

Figure 3 (Irbehctz 07)

A scatter plot with a curve showing the relationship between Irbesartan dose (mg/day) on the x-axis and mmHg reduction on the y-axis. The graph illustrates the placebo-subtracted reduction in trough systolic blood pressure (SeSBP) as dose increases, leveling off at higher doses.*

FDA Label Image

Figure 4 (Irbehctz 08)

A line graph depicting the relationship between Irbesartan dose (mg/day) on the x-axis and reduction in trough SeDBP (mmHg) on the y-axis. The graph shows data points and a curve representing the placebo-subtracted reduction, with increasing doses corresponding to greater reductions up to a plateau.*

FDA Label Image

Lbl7133513922

Packaging label for Irbesartan and Hydrochlorothiazide 150/12.5 mg tablets by Bryant Ranch Prepack. The label notes the product is comparable to Avalide 150/12.5 mg tablets by Winthrop U.S., contains 30 tablets, and includes storage instructions at 20°-25°C (68°-77°F). The label also displays the NDC 71335-1392, lot number 1523487, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.